NDC 0121-1018-30
Buprenorphine and Naloxone 2 mg/1
buprenorphine hydrochloride and naloxone hydrochloride · TABLET
Buprenorphine and Naloxone is a tablet containing buprenorphine hydrochloride and naloxone hydrochloride at a strength of 2 mg/1. Manufactured by PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma.
Key Facts
- Brand Name
- Buprenorphine and Naloxone
- Generic Name
- buprenorphine hydrochloride and naloxone hydrochloride
- NDC Code (Package)
0121-1018-30- NDC Code (Product)
0121-1018- Manufacturer
- PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma
- Strength
- 2 mg/1
- Dosage Form
- TABLET
- Route
- SUBLINGUAL
- Marketing Status
- DEA Schedule
- Schedule III (Controlled)
- Application #
- ANDA204431
- Marketing Start
- 09/05/2023
Recall History
No Recall HistoryView Full Drug Page
Buprenorphine and Naloxone — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.